edtech Value proposition
[Automatic translation follows] Continuing education specialized in biomedicines
The MabDesign association was created in 2014 to support the French industrial biomedicine sector. With its QUALIOPI certification, MabDesign is developing a quality continuing education offer to meet the needs of companies and laboratories in the biomedicine sector.
Discover our evolving online training offer and follow our news on this LinkedIn page!
Immunotherapy, Master Classes, Science, MTI, Skills, and entrepreneurshipOriginal language
Formation continue spécialisée dans les biomédicaments
L’association MabDesign a été créée en 2014 afin d’accompagner la filière française industrielle des biomédicaments. Fort de sa certification QUALIOPI, MabDesign développe une offre de formation continue de qualité pour répondre aux besoins des entreprises et des laboratoires du secteur des biomédicaments.
Découvrez notre offre de formation évolutive en ligne et suivez nos actualités sur cette page LinkedIn !
Immunothérapie, Master Classes, Science, MTI, Compétences, and entreprenariat
- https://www.mabdesign-formation.fr/formations
- Website is disabled or domain is for sale
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Pierre Fabre Laboratories Pharmaceutical, Pharmaceutical Manufacturing | Pierre Fabre Laboratories Pharmaceutical, Pharmaceutical Manufacturing | Other 21 Apr 2024 | | |
 Centre-Val de Loire Region National and local authorities, Government Administration | Centre-Val de Loire Region National and local authorities, Government Administration | Other 19 Jul 2023 | | |
 Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Leem Startup accelerator & VC, Pharmaceutical Manufacturing | Other 14 Feb 2019 | | |
 Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Other 12 Jul 2019 | | |
 INVIVOLIM Biotechnology, Biotechnology Research | INVIVOLIM Biotechnology, Biotechnology Research | Other 6 Mar 2019 | | |